BioCryst 製藥公司
US ˙ NasdaqGS ˙ US09058V1035

簡介

本頁面提供了有關 Alane P Barnes 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Alane P Barnes已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:BCRX / BioCryst Pharmaceuticals, Inc. Chief Legal Officer 400,703
如何解讀這些圖表

以下圖表顯示了在Alane P Barnes進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

BCRX / BioCryst Pharmaceuticals, Inc.內部人士買入 - 短期收益分析

在這一部分,我們分析了在 BCRX / BioCryst Pharmaceuticals, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最高利潤的
天數
達到最高利潤時的
價格
最高
淨利 ($)
最高回報率(%)
2024-05-13 BCRX Barnes Alane P 5,000 5.5300 5,000 5.5300 27,650 357 11.0300 27,500 99.46
2019-11-18 BCRX Barnes Alane P 20,000 1.4500 20,000 1.4500 29,000

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

BCRX / BioCryst Pharmaceuticals, Inc. Insider Trades
BCRX / BioCryst Pharmaceuticals, Inc.內部人士賣出 - 短期虧損分析

在這一部分,我們分析了在 BCRX / BioCryst Pharmaceuticals, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最低利潤的
天數
達到最低利潤時的
價格
避免的
最高損失金額($)
避免的
最高損失率($)
2025-12-02 BCRX Barnes Alane P 50,906 7.2136 50,906 7.2136 367,216 65 6.2400 -49,562 -13.50
2021-05-11 BCRX Barnes Alane P 102,780 12.0400 102,780 12.0400 1,237,471
2018-11-30 BCRX Barnes Alane P 44,290 9.0700 44,290 9.0700 401,710
2014-03-04 BCRX Barnes Alane P 40,734 12.6300 40,734 12.6300 514,470

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

BCRX / BioCryst Pharmaceuticals, Inc. Insider Trades
歷史內部人交易

該表格顯示了由 Alane P Barnes 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2026-05-15 2026-05-13 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -62,500 400,703 -13.49 9.54 -596,250 3,822,707
2026-05-15 2026-05-13 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 62,500 463,203 15.60 5.04 315,000 2,334,543
2026-03-18 2026-03-16 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -150,000 400,703 -27.24 9.15 -1,372,500 3,666,432
2026-03-18 2026-03-16 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 150,000 550,703 37.43 5.51 826,500 3,034,374
2025-12-23 2025-12-22 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -21,773 398,751 -5.18 7.65 -166,563 3,050,445
2025-12-23 2025-12-19 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -16,902 420,524 -3.86 7.41 -125,244 3,116,083
2025-12-19 2025-12-17 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
A - Award 121,700 437,426 38.55
2025-12-16 2025-12-15 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -21,210 315,726 -6.29 7.65 -162,256 2,415,304
2025-12-16 2025-12-12 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -8,540 336,936 -2.47 7.57 -64,648 2,550,606
2025-12-03 2025-12-03 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -19,770 345,476 -5.41 7.65 -151,240 2,642,891
2025-12-03 2025-12-02 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale -50,906 365,246 -12.23 7.21 -367,216 2,634,739
2025-12-03 2025-12-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -91,004 416,152 -17.94 7.10 -646,511 2,956,427
2025-12-03 2025-12-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 91,004 507,156 21.87 3.22 293,033 1,633,042
2024-12-23 2024-12-19 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -2,461 412,729 -0.59 7.39 -18,187 3,050,067
2024-12-23 2024-12-19 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
A - Award 120,700 415,190 40.99
2024-12-17 2024-12-14 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -8,613 294,490 -2.84 7.53 -64,856 2,217,510
2024-05-15 2024-05-13 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
P - Purchase 5,000 300,762 1.69 5.53 27,650 1,663,214
2023-12-20 2023-12-19 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -2,482 293,539 -0.84 6.05 -15,016 1,775,911
2023-12-18 2023-12-14 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -4,015 296,021 -1.34 6.43 -25,816 1,903,415
2023-12-18 2023-12-14 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
A - Award 64,000 300,036 27.11
2022-12-21 2022-12-19 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
A - Award 34,000 232,770 17.11
2022-12-19 2022-12-15 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -4,175 198,770 -2.06 10.88 -45,424 2,162,618
2022-01-13 2021-12-14 4/A BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
A - Award 55,000 201,969 37.42
2021-12-16 2021-12-14 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 164,000 164,000
2021-12-16 2021-12-14 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
A - Award 75,000 221,969 51.03
2021-05-13 2021-05-12 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise -35,852 0 -100.00
2021-05-13 2021-05-12 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise 35,852 146,127 32.51 4.73 169,580 691,181
2021-05-13 2021-05-11 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise -68,000 0 -100.00
2021-05-13 2021-05-11 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise -33,132 0 -100.00
2021-05-13 2021-05-11 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise -1,648 35,852 -4.39
2021-05-13 2021-05-11 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale -102,780 110,275 -48.24 12.04 -1,237,471 1,327,711
2021-05-13 2021-05-11 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise 68,000 213,055 46.88 5.45 370,600 1,161,150
2021-05-13 2021-05-11 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise 33,132 145,055 29.60 1.42 47,047 205,978
2021-05-13 2021-05-11 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise 1,648 111,923 1.49 4.73 7,795 529,396
2020-12-17 2020-12-15 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 280,000 280,000
2020-12-15 2020-12-11 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise X -13,741 0 -100.00
2020-12-15 2020-12-11 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -13,741 108,061 -11.28 7.96 -109,378 860,166
2020-12-15 2020-12-11 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 13,741 121,802 12.72 4.15 57,025 505,478
2020-12-08 2020-12-04 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise X -13,741 13,741 -50.00
2020-12-08 2020-12-04 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -13,741 108,061 -11.28 6.23 -85,606 673,220
2020-12-08 2020-12-04 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 13,741 121,802 12.72 4.15 57,025 505,478
2020-12-07 2020-12-03 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 17,000 17,000
2020-02-25 2020-02-21 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 12,400 12,400
2020-02-19 2020-02-14 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 21,700 21,700
2019-12-19 2019-12-17 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 190,000 190,000
2019-11-18 2019-11-18 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
P - Purchase 20,000 102,061 24.37 1.45 29,000 147,988
2019-01-03 2019-01-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -423 77,530 -0.54 8.07 -3,414 625,667
2018-12-21 2018-12-20 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 190,000 190,000
2018-12-04 2018-11-30 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise -25,000 25,000 -50.00
2018-12-04 2018-11-30 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale -44,290 77,953 -36.23 9.07 -401,710 707,034
2018-12-04 2018-11-30 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise 25,000 122,243 25.71 1.42 35,500 173,585
2018-05-17 2018-05-15 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise -12,500 8,132 -60.59
2018-05-17 2018-05-15 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -3,004 95,264 -3.06 5.91 -17,754 563,010
2018-05-17 2018-05-15 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise 12,500 98,268 14.57 1.42 17,750 139,541
2018-03-02 2018-02-28 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise -6,709 0 -100.00
2018-03-02 2018-02-28 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise 6,709 85,768 8.49 3.26 21,871 279,604
2018-01-23 2018-01-20 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -1,961 77,129 -2.48 5.59 -10,962 431,151
2018-01-03 2018-01-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -459 79,090 -0.58 4.91 -2,254 388,332
2017-12-22 2017-12-20 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 62,500 62,500
2017-09-05 2017-08-31 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 18,600 18,600
2017-03-01 2017-02-27 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 150,000 150,000
2017-01-24 2017-01-20 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -2,599 75,497 -3.33 5.95 -15,464 449,207
2017-01-03 2017-01-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -1,281 78,096 -1.61 6.33 -8,109 494,348
2016-09-16 2016-09-14 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -8,357 79,377 -9.53 4.27 -35,684 338,940
2016-05-25 2016-05-23 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 91,004 91,004
2016-03-03 2016-03-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -687 85,416 -0.80 2.13 -1,463 181,936
2016-02-01 2016-01-29 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise -19,368 20,632 -48.42
2016-02-01 2016-01-29 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise 19,368 85,057 29.48 1.42 27,503 120,781
2016-01-22 2016-01-20 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -2,599 65,689 -3.81 7.55 -19,622 495,952
2016-01-05 2016-01-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -1,281 68,288 -1.84 10.32 -13,220 704,732
2015-12-31 2015-12-29 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 43,997 43,997
2015-06-22 2015-06-19 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -3,000 68,876 -4.17 15.00 -45,000 1,033,140
2015-06-16 2015-05-13 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 17,000 17,000
2015-03-03 2015-03-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -1,120 71,876 -1.53 10.20 -11,424 733,135
2015-01-22 2015-01-20 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -2,210 72,370 -2.96 11.17 -24,686 808,373
2015-01-05 2015-01-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 23,200 23,200
2015-01-05 2015-01-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -2,453 74,580 -3.18 12.16 -29,828 906,893
2015-01-05 2015-01-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
A - Award 4,800 77,033 6.65
2014-12-23 2014-12-19 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 17,000 17,000
2014-05-28 2014-05-26 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 17,000 17,000
2014-03-07 2014-03-04 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise -10,000 90,000 -10.00
2014-03-07 2014-03-04 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise -2,518 27,482 -8.39
2014-03-07 2014-03-04 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise -6,156 35,844 -14.66
2014-03-07 2014-03-04 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise -12,500 37,500 -25.00
2014-03-07 2014-03-04 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale -40,734 71,622 -36.25 12.63 -514,470 904,586
2014-03-07 2014-03-04 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise 10,000 112,356 9.77 1.42 14,200 159,546
2014-03-07 2014-03-04 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise 2,518 102,356 2.52 4.15 10,450 424,777
2014-03-07 2014-03-04 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise 6,156 99,838 6.57 6.68 41,122 666,918
2014-03-07 2014-03-04 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise 12,500 93,682 15.40 4.73 59,125 443,116
2014-03-07 2014-03-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -1,090 81,182 -1.32 11.69 -12,742 949,018
2014-02-04 2014-01-20 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 18,000 18,000
2014-02-04 2014-01-20 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
A - Award 27,000 81,487 49.55
2014-01-15 2014-01-14 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise -13,500 0 -100.00
2014-01-15 2014-01-14 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -1,491 54,487 -2.66 10.87 -16,207 592,274
2014-01-15 2014-01-14 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise 13,500 55,978 31.78 1.20 16,200 67,174
2014-01-03 2014-01-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -2,453 42,478 -5.46 7.60 -18,643 322,833
2013-08-26 3 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
41,931
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)